{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "pubchem:11025495",
      "entity_text" : "cholesterol",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0800" ],
      "Organ" : [ "uberon:UBERON:0007023" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Colesevelam was evaluated in a large clinical trial program in adults with type 2 diabetes, wherein this agent was shown to significantly improve glycemic control (while also significantly reducing LDL cholesterol levels) when added to existing antidiabetes therapy in patients with type 2 diabetes.",
  "reading_complete" : "2020-07-28T15:35:26Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T15:33:01Z",
  "trigger" : "levels",
  "evidence" : [ "cholesterol levels" ],
  "pmc_id" : "3632187",
  "score" : 0
}